Macroprolactin as etiology of hyperprolactinemia. Method for detection and clinical characterization of the entity in 39 patients;Macroprolactina como causa de hiperprolactinemia. Método de detección y caracterización clínica de la entidad en 39 pacientes

Revista Clinica Espanola

Volumn 203, Issue 10, 2003, Pages 459-464

  Garcia Menendez L ^a,c   Diez Hernandez A ^a   Ciriza de los Rios C ^a   Delgado Gomez M ^a   Orejas Garcia A ^a   Fernandez Erales A L ^b   Gonzalez Mateo C ^a   Fernandez Fernandez M ^a  

^a HOSPITAL EL BIERZO   (Spain)

^b HOSPITAL DE LEÓN   (Spain)

^c NONE   (Spain)

Author keywords

Hyperprolactinemia; Macroprolactin; Polythylene glycols

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; MACROGOL; PROLACTIN;

ADOLESCENT; ADULT; ARTICLE; BENIGN TUMOR; CHILD; CLINICAL FEATURE; FEMALE; FOLLOW UP; GALACTORRHEA; HIRSUTISM; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; INCIDENCE; INFERTILITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; OBESITY; OLIGOMENORRHEA; PRECIPITATION; PRIMARY AMENORRHEA; PROLACTIN BLOOD LEVEL; RETROSPECTIVE STUDY;

EID: 0242609273     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2565(03)71328-9     Document Type: Article

References (27)

1. Suh HK, Frantz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 1974;39:928-35.
2. Smith CR, Norman CR. Prolactin and growth hormone: molecular heterogeneity and measurement in serum. Ann Clin Biochem 1990;27:542-50.
3. Hattori N, Ishihara T, Ikekubo K, Moridera K, Hino M, Kurohachi H. Autoantibody to human prolactin in patients with idiopatic hyperprolactinemia. J Clin Endocrinol Metab 1992;75(5):1226-9.
4. Lindstedt G. Endogenous antibodies against prolactin - a «new» cause of hyperprolactinemia. Eur J Endocrinol 1994;130:429-32.
5. Cavaco B, Leite V, Santos MA, Arranhado E, Sobrinho LG. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma. J Clin Endocrinol Metab 1995;80:2342-6.
6. Hattori N. The frecuency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. J Clin Endocrinol Metab 1996;81 (2):586-90.
7. Hattori N, Inagabi C. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. J Clin Endocrinol Metab 1997;82:3107-10.
8. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H. Effects of anti-prolactin autoantibodies on serum prolactin measurements. Eur J Endocrinol 1994;130:434-7.
9. Bjoro T, Morkrid L, Wergeland R, Turter A, Kvistborg A, Sand T, Torjesen P. Frequency of hyperprolactinemia due to large molecular weight prolactin (150-170 kD PRL). Scand J Clin Lab Investig 1995;55: 139-47.
10. Fahie-Wilson MN, Soule SG. Macroprolactinaemia: contribution to hyperprolactinaemia in a disctrict general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 1997;34:252-8.
11. Leaños A, Pascoe D, Fraga A, Blanco F. Anti-prolactin autoantibodies in sistemic lupus erythematosus patients with associated hyperprolactinemia. Lupus 1998;7:398-403.
12. Andersen AN, Pedersen H, Djursing H, Andersen BN, Friesen HG. Bioactivity of prolactin in a woman with an excess of large molecular size prolactin, persistent hyperprolactinemia and spontaneous conception. Fertil Steril 1982;38:625-8.
13. Leaños A, Pascoe D, Chávez KA, Blanco F. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus. J Clin Endocrinol Metab 2001; 86(6):2619-24.
14. Leslie H, Courtney CH, Bell PM, Hadden DR, McCance DR, Ellis PK, et al. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 2001;86(6):2743-6.
15. Cavaco B, Prazeres S, Santos MA, Sobrinho LG, Leite V. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays. J Endocrinol Invest 1999;22:(3):203-8.
16. John R, Mc Dowell IFW, Scanlon MF, Ellis AR. Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers. Clin Chem 2000;46(6):884-5.
17. Fahie Wilson MN. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin. Clin Chem 2000;46(12):2022-3.
18. Gilson G, Schmit P, Thix J, Hoffman JP, Humbel RL. Prolactin results for samples containing macroprolactin are method and sample dependent. Clin Chem 2001;47(2):331-3.
19. Vieira JGH, Tachibana TT, Obara LH, Maciel RMB. Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin Chem 1998;44(8):1758-9.
20. Olukoga AO, Kane JW. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol 1999;51(1):119-26.
21. Fahie-Wilson M, Brunsden P, Surrey J, Everitt A. Macroprolactin and the Roche Elecsys prolactin assay: characteristics of the reaction and detection by precipitation with polyethylene glycol. Clin Chem 2000;46(12): 1993-5.
22. Whittaker PG, Wilcox T, Lind T. Maintained fertility in a patient with hyperprolactinemia due to big big prolactin. J Clin Endocrinol Metab 1981; 53:863-6.
23. Jackson RD, Wortsman J, Malarkey WB. Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab 1985;61:258-64.
24. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H. A normal ovulatory woman with hyperprolactinemia: presence of antiprolactin autoantibody and the regulation of prolactin secretion. Acta Endocrinol 1992;26:497-500.
25. Olukoga AO, Kane J. Antiprolactin autoantibodies and hyperprolactinemia. Eur J Endocrinol 1995;133:463-4.
26. Diver MJ, Ewins DL, Worth RC, Bowles S, Ahlquist JA, Fahie-Wilson MN. An unusual form of big big (macro) prolactin in a pregnant patient. Clin Chem 2001;47(2):346-8.
27. Aron DC, Howlett TA. Pituitary incidentalomas. Endocrinol Clin North Am 2000;29:205-21.